{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:38:57Z","timestamp":1793093937938,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010313","name":"Heidelberg Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY036593"],"award-info":[{"award-number":["EY036593"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xops.2026.101097","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:40:58Z","timestamp":1770050458000},"page":"101097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors"],"prefix":"10.1016","volume":"6","author":[{"given":"Abdelrahman M.","family":"Elhusseiny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad F.","family":"Alzein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-2720","authenticated-orcid":false,"given":"Felipe A.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101097_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2026.101097_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101303","article-title":"The relationship between intraocular pressure and glaucoma: an evolving concept","volume":"103","author":"Asrani","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2026.101097_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101097_bib4","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1016\/j.ophtha.2020.10.022","article-title":"Primary open-angle glaucoma preferred practice pattern","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101097_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in adults-screening, diagnosis, and management: a review","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2026.101097_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2025.100236","article-title":"Metabolite patterns of the carbonic anhydrase inhibitors brinzolamide and dorzolamide: potential markers for the route of application","volume":"8","author":"Jin","year":"2025","journal-title":"J Chromatogr Open"},{"key":"10.1016\/j.xops.2026.101097_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003088-200241030-00004","article-title":"Clinical pharmacokinetics of dorzolamide","volume":"41","author":"Martens-Lobenhoffer","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xops.2026.101097_bib8","series-title":"Proceedings of the Manfred Donike Workshop 41th Cologne Workshop on Dope Analysis 26th March to 3rd April 2023","year":"2024"},{"key":"10.1016\/j.xops.2026.101097_bib9","first-page":"93","article-title":"Anorexia, depression and dementia induced by dorzolamide eyedrops (Trusopt)","volume":"34","author":"thoe Schwartzenberg","year":"1999","journal-title":"Can J Ophthalmol J Can Ophtalmol"},{"key":"10.1016\/j.xops.2026.101097_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaophthalmol.2021.5977","article-title":"Serious adverse events of oral and topical carbonic anhydrase inhibitors","volume":"140","author":"Popovic","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101097_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5021\/ad.2014.26.5.645","article-title":"Toxic epidermal necrolysis in a patient with HLA-B\u22175901 haplotype caused by topical and oral carbonic anhydrase inhibitors","volume":"26","author":"Cheon","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.xops.2026.101097_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5021\/ad.2008.20.4.260","article-title":"Toxic epidermal necrolysis induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide","volume":"20","author":"Chun","year":"2008","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.xops.2026.101097_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0960327120918307","article-title":"A review of neuropsychiatric adverse events from topical ophthalmic brimonidine","volume":"39","author":"Cimolai","year":"2020","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.xops.2026.101097_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000328585","article-title":"Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol","volume":"226","author":"Bali","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2026.101097_bib16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.13499","article-title":"Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function","volume":"84","author":"Hoffmanov\u00e1","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xops.2026.101097_bib17","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s11064-021-03390-2","article-title":"Anticonvulsant effects of carbonic anhydrase inhibitors: the enigmatic link between carbonic anhydrases and electrical activity of the brain","volume":"46","author":"Ozsoy","year":"2021","journal-title":"Neurochem Res"},{"key":"10.1016\/j.xops.2026.101097_bib18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/14756366.2020.1766455","article-title":"Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders","volume":"35","author":"Blandina","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.xops.2026.101097_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jad.2024.12.064","article-title":"Hippocampus carbonic anhydrase 1 via ERK pathway may be involved in depressive like behaviors","volume":"373","author":"Cheng","year":"2025","journal-title":"J Affect Disord"},{"key":"10.1016\/j.xops.2026.101097_bib20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archopht.1977.04450080088009","article-title":"Carbonic anhydrase inhibitor side effects. Serum chemical analysis","volume":"95","author":"Epstein","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101097_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310985","article-title":"From meta-analysis to Mendelian randomization: unidirectional perspectives on the association of glaucoma with depression and anxiety","volume":"19","author":"Deng","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2026.101097_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0960327120918307","article-title":"A review of neuropsychiatric adverse events from topical ophthalmic brimonidine","volume":"39","author":"Cimolai","year":"2020","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.xops.2026.101097_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ophtha.2006.02.056","article-title":"Topical beta-blockers are not associated with an increased risk of treatment for depression","volume":"113","author":"Kaiserman","year":"2006","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:38:47Z","timestamp":1778924327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666914526000357"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101097","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101097"}}